缺血型烟雾病的血管内治疗

Endovascular treatment of ischemic moyamoya disease

烟雾病是一种相对少见的脑血管病。烟雾病首选颅内外血管吻合术。不过,由于存在一定术后并发症和症状再发风险,外科手术治疗仍存在着一定的争议。近年来,随着微创介入技术的发展,动脉粥样硬化性缺血性脑血管病的血管内治疗已在全球广泛开展,部分医生也开始尝试对缺血型烟雾病进行血管内治疗,但其疗效和安全性尚不明确。文章对缺血性型烟雾病的血管内治疗进行了综述。

Moyamoya disease is a relatively rare cerebrovascular disease.Extracranial and intracranial vascular bypass is the first choice for moyamoya disease.However,due to the risk of complications and symptoms recurrence after surgery,there is still some controversy about surgical treatment.In recent years,with the development of minimally invasive interventional technology,the endovascular treatment of atherosclerotic ischemic cerebrovascular disease has been widely carried out in the world.Some doctors are also beginning to try endovascular treatment of ischemic moyamoya disease,but its efficacy and safety are still unclear.This article reviews the endovascular treatment of ischemic moyamoya disease.